| 000 | 01790 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517215835.0 | ||
| 264 | 0 | _c20190913 | |
| 008 | 201909s 0 0 eng d | ||
| 022 | _a1477-2566 | ||
| 024 | 7 |
_a10.1016/j.jcyt.2018.03.037 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRao, Mahendra S | |
| 245 | 0 | 0 |
_aIllustrating the potency of current Good Manufacturing Practice-compliant induced pluripotent stem cell lines as a source of multiple cell lineages using standardized protocols. _h[electronic resource] |
| 260 |
_bCytotherapy _c06 2018 |
||
| 300 |
_a861-872 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAstrocytes _xcytology |
| 650 | 0 | 4 | _aCell Differentiation |
| 650 | 0 | 4 |
_aCell Engineering _xmethods |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aCell Lineage |
| 650 | 0 | 4 |
_aDopaminergic Neurons _xcytology |
| 650 | 0 | 4 |
_aEndothelial Cells _xcytology |
| 650 | 0 | 4 |
_aGuideline Adherence _xstandards |
| 650 | 0 | 4 |
_aHepatocytes _xcytology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInduced Pluripotent Stem Cells _xcytology |
| 650 | 0 | 4 |
_aMesoderm _xcytology |
| 650 | 0 | 4 |
_aNeural Stem Cells _xcytology |
| 650 | 0 | 4 |
_aPractice Guidelines as Topic _xstandards |
| 650 | 0 | 4 | _aReference Standards |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 |
_aRetina _xcytology |
| 650 | 0 | 4 |
_aTissue Banks _xstandards |
| 700 | 1 | _aPei, Ying | |
| 700 | 1 | _aGarcia, Thelma Y | |
| 700 | 1 | _aChew, Shereen | |
| 700 | 1 | _aKasai, Toshiharu | |
| 700 | 1 | _aHisai, Tomoko | |
| 700 | 1 | _aTaniguchi, Hideki | |
| 700 | 1 | _aTakebe, Takanori | |
| 700 | 1 | _aLamba, Deepak A | |
| 700 | 1 | _aZeng, Xianmin | |
| 773 | 0 |
_tCytotherapy _gvol. 20 _gno. 6 _gp. 861-872 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jcyt.2018.03.037 _zAvailable from publisher's website |
| 999 |
_c28423053 _d28423053 |
||